BGXX - brightgreen.us Company Long-Term Liabilities

The market dynamics for Bright Green (BGXX) securities on the GURU.Markets platform are recorded at 0.00, driven by Bright Green transitioning to industrial raw material production in accordance with DEA standards. The business relies on supplying high-quality components to pharmaceutical centers, thereby minimizing agricultural risks. The company's stability is based on its ownership of patents and quotas, which guarantee high future profits and free cash flow.

Bright Green (BGXX) Company Long-Term Liabilities: for the period 04/28/2023 - 09/21/2024

Bright Green Corporation (BGXX) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Price Performance Chart Bright Green Corp.|BGXX - Analyst Consensus Forecast

- market capitalization statistics:

Market Valuation Bright Green|BGXX - Total Company Value

- shareholders' equity book value data:

Net Asset Value per Share Bright Green|BGXX - Company Net Assets|Market Value to Book Value brightgreen.us|BGXX - Company Total Assets

- debt level and financial liquidity data:

- earnings and market multiples details:

BGXX - Company Net Income

Analysis of all company metrics:Bright Green

Finished products of Bright Green Corporation

Long-term debt determines the scale of strategic borrowings required to scale capital-intensive projects. For Bright Green (BGXX), these obligations fund the construction of high-tech greenhouses for pharmaceutical needs. When analyzing the issuer's long-term liability statistics, it is essential to correlate loan dynamics with revenue growth rates. An increase in debt is justified only by a high return on invested capital. Debt loads that exceed operational efficiency create critical liquidity risks.

Competitors of Bright Green (BGXX)

Company Long-Term Loans and Borrowings INDV|Collegium Pharmaceutical, Inc. - Company Long-Term Debts|Cronos Group Inc (CRON) - Company Long-Term Liabilities|Tweed (CGC) - Company Long-Term Debt|Long-Term Debt Canna Cabana (HITI)|Company Long-Term Liabilities ACB|ACHV: Company Long-Term Loans and Borrowings|Company Long-Term Debts SKYE|ANEB: Long-Term Liabilities|Company Long-Term Debts INCR (InterCure)|Company Long-Term Debts Nutriband Inc NTRB|NSRX - Company Long-Term Debt|Company Long-Term Loans and Borrowings IGC (IGC Pharma, Inc.)|mirapharmaceuticals.com (MIRA) - Company Long-Term Debt|Company Long-Term Liabilities Flora Growth Corp|IMCC (IM Cannabis Corp) - Company Long-Term Debts|Company Long-Term Debt ADIL|Company Long-Term Debt Artelo Biosciences (ARTL)|ENSC (ensysce.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts TTNP (Titan Pharmaceuticals, Inc.)|Long-Term Debt Volume Greenlane Holdings, Inc. (GNLN)|InMed Pharma - Company Long-Term Debts|Long-Term Indebtedness Akanda Inc (AKAN)|ENVB: Company Long-Term Debts|hempaccoinc.com - Company Long-Term Loans and Borrowings